COVID-19 vaccination surveillance: a public health commitment
Keywords:
COVID-19, immunization programs, mass vaccination, public health surveillance, safetyReferences
Joob B., Wiwanitkit V. Safety and BNT162b2 mRNA COVID-19 vaccination. Acta Biomed. 2021.
Burgess RA, Osborne RH, Yongabi KA, Greenhalgh T, Gurdasani D, Kang G, et al. The COVID-19 vaccines rush: participatory community engagement matters more than ever. Lancet. 2021;397(10268):8-10.
Vigezzi GP, Lume A, Minerva M, Nizzero P, Biancardi A, Gianfredi V, et al. Safety surveillance after BNT162b2 mRNA COVID-19 vaccination: results from a cross-sectional survey among staff of a large Italian teaching hospital. Acta Biomed. 2021;92(S6):e2021450.
Gianfredi V, Minerva M, Casu G, Capraro M, Chiecca G, Gaetti G, et al. Immediate adverse events following COVID-19 immunization. A cross-sectional study of 314,664 Italian subjects. Acta Biomed. 2021;92(S6):e2021487.
Odone A, Gianfredi V, Sorbello S, Capraro M, Frascella B, Vigezzi GP, et al. The Use of Digital Technologies to Support Vaccination Programmes in Europe: State of the Art and Best Practices from Experts’ Interviews. 2021;9(10):1126.
Gianfredi V, Moretti M, Lopalco PL. Countering vaccine hesitancy through immunization information systems, a narrative review. Hum Vaccin Immunother. 2019;15(11):2508-26.
Balzarini F, Frascella B, Oradini-Alacreu A, Gaetti G, Lopalco PL, Edelstein M, et al. Does the use of personal electronic health records increase vaccine uptake? A systematic review. Vaccine. 2020;38(38):5966-78.
Menachemi N, Collum TH. Benefits and drawbacks of electronic health record systems. Risk Manag Healthc Policy. 2011;4:47-55.
Gianfredi V, Balzarini F, Gola M, Mangano S, Carpagnano LF, Colucci ME, et al. Leadership in Public Health: Opportunities for Young Generations Within Scientific Associations and the Experience of the "Academy of Young Leaders". Front Public Health. 2019;7:378.
WHO. Global manual on surveillance of adverse events following immunization. 2014.
Gianfredi V, Paoloni MC, Villarini M, Moretti M. [Active surveillance evaluation of anti-HPV vaccine adverse events in Umbria region]. Clin Ter. 2017;168(5):e327-e32.
Gianfredi V, Grisci C, Nucci D, Parisi V, Moretti M. [Communication in health.]. Recenti Prog Med. 2018;109(7):374-83.
Di Pasquale A, Bonanni P, Garçon N, Stanberry LR, El-Hodhod M, Da Silva FT. Vaccine safety evaluation: practical aspects in assessing benefits and risks. Vaccine. 2016;34(52):6672-80.
Kumar D, Chandra R, Mathur M, Samdariya S, Kapoor N. Vaccine hesitancy: understanding better to address better. Israel journal of health policy research. 2016;5(1):1-8.
Bollaerts K, de Smedt T, McGee C, Emborg HD, Villa M, Alexandridou M, et al. ADVANCE: Towards near real-time monitoring of vaccination coverage, benefits and risks using European electronic health record databases. Vaccine. 2020;38 Suppl 2:B76-b83.
WHO. COVID-19 vaccines: safety surveillance manual. 2021.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Publisher
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
